RNXT RenovoRx, Inc.
RenovoRx, Inc. (RNXT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: May 19, 2026 , by VOLL MARK .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| VOLL MARK | Chief Financial Officer | Buy | 25,000 | $0.79 | $19.7K | 142,380 | |
| VOLL MARK | Chief Financial Officer | Buy | 97,200 | $0.00 | $0 | 97,200 | |
| Marton Laurence | Director | Buy | 9,720 | $0.00 | $0 | 9,720 | |
| Bagai Shaun | Chief Executive Officer | Buy | 24,300 | $0.00 | $0 | 313,357 | |
| Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $1.00 | $10.0K | 798,460 | |
| Agah Ramtin | Chief Medical Officer | Buy | 9,795 | $0.86 | $8.4K | 788,460 | |
| Agah Ramtin | Chief Medical Officer | Buy | 205 | $0.83 | $169 | 778,665 | |
| Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $0.90 | $4.5K | 340,040 | |
| Bagai Shaun | Chief Executive Officer | Buy | 5,000 | $0.85 | $4.3K | 335,040 | |
| Agah Ramtin | Chief Medical Officer | Buy | 12,000 | $0.85 | $10.2K | 778,460 | |
| Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $0.96 | $9.6K | 766,460 | |
| Agah Ramtin | Chief Medical Officer | Buy | 12,000 | $0.80 | $9.6K | 756,460 | |
| Agah Ramtin | Chief Medical Officer | Buy | 10,000 | $0.80 | $8.0K | 744,460 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.